W Health Ventures closes Fund II at Rs 700 Cr

W Health Ventures, a venture capital firm specializing in healthcare, has successfully closed its second fund at Rs 700 crore. This figure surpasses the initial target of Rs 630 crore. The firm aims to utilize the capital to support 8-10 healthcare startups over the next four years.

India is currently experiencing a significant inflection point in the healthcare sector, characterized by a growing demand for services coupled with limited supply. This imbalance presents a unique opportunity for the creation of enduring businesses. According to Pankaj Jethwani, Managing Partner of W Health Ventures, the firm's strategy centers on the challenging yet rewarding nature of healthcare entrepreneurship.

The VC firm has already made two investments via Fund II—Everhope Oncology and Everbright Health. It boasts a team of 50 members, including physicians, operators, and technologists, dedicated to identifying gaps in the healthcare sector and evaluating potential investment opportunities. Established in 2020, W Health Ventures focuses on the US-India healthcare corridor, typically deploying Rs 30-50 crore across two to three startups annually.

To date, the firm's portfolio encompasses Elevate Now, Nivaan, and Hoola Health. The collective reach of these portfolio companies extends to 25 million patients. Jethwani emphasizes that W Health Ventures does not simply import a Silicon Valley model and hope for success in India. Instead, the firm targets areas with the highest structural mismatches in the healthcare system and remains committed to addressing these issues for an extended period before developing any solutions.